NO20085215L - Nye pyridinanaloger - Google Patents

Nye pyridinanaloger

Info

Publication number: NO20085215L
Authority: NO; Norway
Prior art keywords: new pyridine; pyridine analogs; formula; analogs; new
Prior art date: 2006-07-04

Application number

NO20085215A

Other languages

English (en)

Norwegian (no)

Inventor

Ruth Bylund

Fabrizio Giordanetto

Peter Bach

Johan Johansson

Thomas Antonsson

Lotta Jakobsson

David Brown

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-07-04

Filing date

2008-12-15

Publication date

2009-01-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38894825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20085215(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-12-15 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2009-01-13 Publication of NO20085215L publication Critical patent/NO20085215L/no

Links

150000003222 pyridines Chemical class 0.000 title abstract 2
208000024172 Cardiovascular disease Diseases 0.000 abstract 1
239000002172 P2Y12 inhibitor Substances 0.000 abstract 1
239000003146 anticoagulant agent Substances 0.000 abstract 1
229960004676 antithrombotic agent Drugs 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)

NO20085215A 2006-07-04 2008-12-15 Nye pyridinanaloger NO20085215L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
SE0601463		2006-07-04
SE0602091		2006-10-04
SE0700059		2007-01-12
PCT/SE2007/000646 WO2008004946A1 (en)	2006-07-04	2007-07-02	New pyridine analogues

Publications (1)

Publication Number	Publication Date
NO20085215L true NO20085215L (no)	2009-01-13

Family

ID=38894825

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20085215A NO20085215L (no)	2006-07-04	2008-12-15	Nye pyridinanaloger

Country Status (16)

Country	Link
US (2)	US20080039437A1 (es)
EP (1)	EP2044050A1 (es)
JP (1)	JP2009542644A (es)
KR (1)	KR20090034935A (es)
AR (1)	AR061805A1 (es)
AU (1)	AU2007270086A1 (es)
BR (1)	BRPI0713967A2 (es)
CA (1)	CA2655633A1 (es)
CL (1)	CL2007001937A1 (es)
EC (1)	ECSP099040A (es)
IL (1)	IL195982A0 (es)
MX (1)	MX2008016548A (es)
NO (1)	NO20085215L (es)
TW (1)	TW200811133A (es)
UY (1)	UY30457A1 (es)
WO (1)	WO2008004946A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008004941A1 (en) *	2006-07-04	2008-01-10	Astrazeneca Ab	New pyridine analogues
US20090018166A1 (en) *	2007-07-13	2009-01-15	Astrazeneca Ab	New Pyridine Analogues X 161
AR072697A1 (es) *	2008-07-07	2010-09-15	Astrazeneca Ab	Compuestos de piridina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastorno de agregacion plaquetaria
EP2750676B1 (en)	2011-08-30	2018-01-10	University of Utah Research Foundation	Methods and compositions for treating nephrogenic diabetes insipidus

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6156758A (en) *	1999-09-08	2000-12-05	Isis Pharmaceuticals, Inc.	Antibacterial quinazoline compounds
US6906063B2 (en) *	2000-02-04	2005-06-14	Portola Pharmaceuticals, Inc.	Platelet ADP receptor inhibitors
WO2001057037A1 (en) *	2000-02-04	2001-08-09	Cor Therapeutics, Inc.	Platelet adp receptor inhibitors
US7452870B2 (en) *	2000-08-21	2008-11-18	Inspire Pharmaceuticals, Inc.	Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7132408B2 (en) *	2000-08-21	2006-11-07	Inspire Pharmaceuticals, Inc.	Composition and method for inhibiting platelet aggregation
US7018985B1 (en) *	2000-08-21	2006-03-28	Inspire Pharmaceuticals, Inc.	Composition and method for inhibiting platelet aggregation
FR2820057A1 (fr) *	2001-01-30	2002-08-02	Ct De Transfert De Technologie	Membrane pour chambre d'encapsulation de cellules produisant au moins une substance biologiquement active et organe bio-artificiel comprenant une telle membrane
MXPA06001601A (es) *	2003-08-13	2006-08-25	Takeda Pharmaceutical	Derivados de 4-pirimidona y su uso como inhibidores de dipeptidilpeptidasa.
KR20060113699A (ko) *	2003-10-03	2006-11-02	포톨라 파마슈티컬스, 인코포레이티드	치환된 이소퀴놀리논
US7749981B2 (en) *	2003-10-21	2010-07-06	Inspire Pharmaceuticals, Inc.	Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7335648B2 (en) *	2003-10-21	2008-02-26	Inspire Pharmaceuticals, Inc.	Non-nucleotide composition and method for inhibiting platelet aggregation
US7504497B2 (en) *	2003-10-21	2009-03-17	Inspire Pharmaceuticals, Inc.	Orally bioavailable compounds and methods for inhibiting platelet aggregation
WO2006012226A2 (en) *	2004-06-24	2006-02-02	Incyte Corporation	N-substituted piperidines and their use as pharmaceuticals
WO2006073361A1 (en) *	2005-01-06	2006-07-13	Astrazeneca Ab	Novel pyridine compounds
CN101511815A (zh) *	2006-07-04	2009-08-19	阿斯利康(瑞典)有限公司	新型吡啶类似物
AU2007270083A1 (en) *	2006-07-04	2008-01-10	Astrazeneca Ab	New pyridine analogues
WO2008004941A1 (en) *	2006-07-04	2008-01-10	Astrazeneca Ab	New pyridine analogues

2007
- 2007-06-28 TW TW096123504A patent/TW200811133A/zh unknown
- 2007-07-02 AU AU2007270086A patent/AU2007270086A1/en not_active Abandoned
- 2007-07-02 KR KR1020097001915A patent/KR20090034935A/ko not_active Withdrawn
- 2007-07-02 JP JP2009518051A patent/JP2009542644A/ja active Pending
- 2007-07-02 US US11/772,269 patent/US20080039437A1/en not_active Abandoned
- 2007-07-02 MX MX2008016548A patent/MX2008016548A/es not_active Application Discontinuation
- 2007-07-02 WO PCT/SE2007/000646 patent/WO2008004946A1/en not_active Ceased
- 2007-07-02 US US12/307,277 patent/US20100069350A1/en not_active Abandoned
- 2007-07-02 CA CA002655633A patent/CA2655633A1/en not_active Abandoned
- 2007-07-02 EP EP07748305A patent/EP2044050A1/en not_active Withdrawn
- 2007-07-02 BR BRPI0713967-5A patent/BRPI0713967A2/pt not_active Application Discontinuation
- 2007-07-03 AR ARP070102973A patent/AR061805A1/es unknown
- 2007-07-03 UY UY30457A patent/UY30457A1/es not_active Application Discontinuation
- 2007-07-03 CL CL200701937A patent/CL2007001937A1/es unknown
2008
- 2008-12-15 NO NO20085215A patent/NO20085215L/no not_active Application Discontinuation
- 2008-12-16 IL IL195982A patent/IL195982A0/en unknown
2009
- 2009-01-07 EC EC2009009040A patent/ECSP099040A/es unknown

Also Published As

Publication number	Publication date
WO2008004946A1 (en)	2008-01-10
MX2008016548A (es)	2009-02-12
JP2009542644A (ja)	2009-12-03
US20080039437A1 (en)	2008-02-14
ECSP099040A (es)	2009-02-27
TW200811133A (en)	2008-03-01
US20100069350A1 (en)	2010-03-18
BRPI0713967A2 (pt)	2012-11-27
IL195982A0 (en)	2009-09-01
UY30457A1 (es)	2008-02-29
KR20090034935A (ko)	2009-04-08
CA2655633A1 (en)	2008-01-10
CL2007001937A1 (es)	2008-07-25
EP2044050A1 (en)	2009-04-08
AR061805A1 (es)	2008-09-24
AU2007270086A1 (en)	2008-01-10

Legal Events

Date	Code	Title	Description
2009-12-07	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20085218L (no)	2009-01-12	Nye pyridinanaloger
NO20085213L (no)	2009-01-13	Nye pyridinanaloger
NO20073101L (no)	2007-07-19	Nye pyridinforbindelser
NO20076682L (no)	2008-03-05	Nye pyridinanaloger
NO20085214L (no)	2009-01-14	Nye pyridinanaloger
NO20085212L (no)	2009-01-12	Nye pyridinanaloger
NO20071504L (no)	2007-05-25	Pyrimidinderivanter.
NO20082124L (no)	2008-06-20	Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
NO20070339L (no)	2007-03-19	1-aza-bicyklo[3 3.1]nonaner
NO20074592L (no)	2007-10-19	Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister
NO20070224L (no)	2007-04-02	2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20090835L (no)	2009-04-23	Nye HIV-reverstranskriptaseinhibitorer
NO20071246L (no)	2007-05-24	Kinazolinonderivater og deres anvendelse som B-RAF-inhibitorer.
NO20082709L (no)	2008-08-13	Kjemiske forbindelser
NO20071245L (no)	2007-05-24	Kinazolinonderivater og deres anvendelse som b-RAF-inhibitorer.
NO20084202L (no)	2008-10-08	4-anilinoquinolin-3-carboksamider som CSF-1R kinase inhibitorer
NO20071776L (no)	2007-04-25	Kinoksaliner som B RAF inhibitorer.
NO20072784L (no)	2007-07-17	Pyridenkarboksamidderivater for anvendelse som anticancer midler
EP1982982A4 (en)	2009-07-22	NEW COUMARINE DERIVATIVE WITH ANTITUM EFFECT
NO20073791L (no)	2007-08-30	Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
NO20074647L (no)	2007-11-09	3,4 dihydro-1H-isoquinolin-2-karboksylsyre-5-ammopyridin-2-yl estere
TW200732323A (en)	2007-09-01	Organic compounds
NO20091683L (no)	2009-05-27	Kjemiske forbindelser
MX2009004746A (es)	2009-05-22	Derivados de 1,2,4-triazol como inhibidores del receptor sigma.
NO20083905L (no)	2008-09-12	Nye pyron-indol derivater og fremgangsmate for deres fremstilling